Clinical Trials on Telemonitoring in India
Total 0 results
Nothing found
Sponsors and Collaborators
- JMI Laboratories
- Pedro Gamito
- Braunschweig Integrated Centre of Systems Biology (BRICS), Germany
- IN-JET APS
- The Fred Hollows Foundation, Australia
- Prof. Jacques SCHRENZEL
- Universitatea de Medicina si Farmacie Iuliu Hatieganu
- Janssen (China) Research & Development Center
- Hazelden Betty Ford Foundation
- Markham Stouffville Hospital
- Nestlé Health Science Belgium
- Fogarty International Center of the National Institute of Health
- Advanced Life Solutions
- Hospital Samaritano Paulista
- Dr. Praveen B.H
- Familien Hede Nielsens Fond
- Physip S.A
- Custom Pharmaceuticals Limited
- Stannah Stairlifts
- UZ Leuven, campus Pellenberg (Belgium)
- View Full List
Medical Conditions
- Epidemic Hemorrhagic Fever
- Skull Base Neoplasms
- Fracture Dislocation of Cervical Spine
- Chlamydophila Infections
- Psoriasis, Arthritic
- Multisystem Proteinopathy
- Endocarditis Infective
- Pulmonary Adenocarcinoma
- Closure; Foramen Ovale
- Spine Surgeries
- Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura
- Cutaneous Leiomyomata With Uterine Leiomyomata
- Philadelphia Chromosome-positive Chronic Myeloid Leukemia in Chronic Phase
- Painless Hysteroscopy
- Fetus or Neonate Affected by External Version Before Labor
- Childhood Langerhans Cell Histiocytosis
- Ewing's Family Tumors
- Tay-Sachs Disease Ganglioside
- Gullian Barre Syndrome
- Predictors of Atrial Fibrillation Recurrences
- View Full List
Drug Interventions
- Neihulizumab
- Azelastine hydrochloride (BAYR9258)
- PET/CT using PET ligands [F-18]FDG and [F-18]DPA-714
- Estradiol+Drospirenone
- Adriamycin
- Semapimod
- NanoDoce (intravesical instillation) - Induction and Maintenance Instillations
- Adapalene Gel 0.3%
- Qingkailing injection 40 ml
- Palliative care group first-line scheme
- Naltrexone 50 mg/day + Cognitive Behavioral Therapy
- Esomeprazole 40mg before
- Redifferentiation with retinoid acid
- Vehicle
- Glimepiride
- High dose pantoprazole infusion
- Cereport
- EFV +TVA
- Mocetinostat - Recommended Phase 2 Dose (70 mg)
- Chemotherapeutic Agent
- View Full List
CROs by country
- Contract Research Organizations in Austria
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Cyprus
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Madagascar
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Portugal
- Contract Research Organizations in Singapore
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Thailand
- Contract Research Organizations in United Arab Emirates
- Contract Research Organizations in Uzbekistan
- Contract Research Organizations in Zimbabwe
- CRO list by country